Results 61 to 70 of about 12,603 (200)

Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: A nationwide study in Hungary. [PDF]

, 2014
We conducted a nationwide, full-population based investigation to evaluate the comparative effectiveness of all marketed second generation antipsychotic drugs (SGA) prescribed for outpatients with the diagnosis of schizophrenia in Hungary.
Bitter, Chen, Dossenbach, Gergely Gyáni, István Bitter, Joris Diels, János Zámbori, Kahn, Kane, Kelin, Klingberg, Lajos Katona, Lauriello, Leucht, Lieberman, László Fehér, Miklós Bacskai, Pál Czobor, Péter Takács, Sellwood, Thomas, Tiihonen, Tiihonen, World Health Organization: The ICD-10 Classification of Mental and Behavioural Disorders, Zsolt Lang   +24 more
core   +1 more source

Associations Between Serum Adipokine, Antipsychotic Exposure, and Clinical Characteristics in Chronic Schizophrenia: A Cross‐Sectional Study

Neuropsychopharmacology Reports, Volume 46, Issue 2, June 2026.
In chronic schizophrenia, serum adiponectin levels were positively associated with antipsychotic dosage, particularly with multi‐acting receptor‐targeted antipsychotics and were influenced by gender and hospitalization period. These findings highlight gender‐specific metabolic regulation and the importance of monitoring adipokines during long‐term ...
Yasuhiro Ohno, Kiyomi Saito, Keita Hanabusa, Ayaka Nakai, Tomoko Nagai, Noriko Hida, Kenji Sanada   +6 more
wiley   +1 more source

The characteristics of cognitive neuroscience tests in a schizophrenia cognition clinical trial: Psychometric properties and correlations with standard measures. [PDF]

, 2020
In comparison to batteries of standard neuropsychological tests, cognitive neuroscience tests may offer a more specific assessment of discrete neurobiological processes that may be aberrant in schizophrenia.
Ball, M Patricia, Barch, Deanna M, Buchanan, Robert W, Chun, Charlotte A, Csernansky, John G, Goff, Donald C, Gold, James M, Green, Michael F, Jarskog, L Fredrik, Javitt, Daniel C, Keefe, Richard SE, Kern, Robert S, Kimhy, David, Kraus, Michael S, Lieberman, Jeffrey A, Marder, Stephen R, McEvoy, Joseph P, McMahon, Robert P, Mesholam-Gately, Raquelle I, Robinson, James, Seidman, Larry J, Walker, Trina M   +21 more
core  

Antipsychotic‐Induced Hyperprolactinemia [PDF]

, 2009
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/90238/1/phco.29.1.64 ...
Bostwick, Jolene R., Ellingrod, Vicki L., Guthrie, Sally K.   +2 more
core   +1 more source

Agitation in Nonverbal Patients With Autism: The Role of Sensory Evaluation in Diagnosis and Management

Clinical Case Reports, Volume 14, Issue 5, May 2026.
ABSTRACT Autism spectrum disorder (ASD) is a complex neurodevelopmental condition often associated with communication barriers, sensory sensitivities, and behavioral challenges, including agitation. Identifying the underlying causes of acute agitation in nonverbal individuals with ASD can be difficult, leading to diagnostic delays and unnecessary ...
Logan Bailey, Justin David Tse, Amitesh Chandra, Sylvia Sudat, Rajkamal Hansra   +4 more
wiley   +1 more source

Ziprasidone in the treatment of mania in bipolar disorder

Neuropsychiatric Disease and Treatment, 2007
Stephen E Nicolson1, Charles B Nemeroff21From the Department of Psychiatry, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA; 2From the Department of Psychiatry and Behavioral Sciences, Emory University, School of Medicine ...
Stephen E Nicolson, Charles B Nemeroff
doaj  

Ziprasidone use Associated with Sexual Hyperarousal

Psychiatry and Clinical Psychopharmacology, 2021
-
Hanife Kocakaya, Zekiye Celikbas, Mesut Yildiz, Emrah Songur, Sedat Batmaz   +4 more
doaj   +1 more source

Response to antipsychotic drugs in treatment-resistant schizophrenia : Conclusions based on systematic review [PDF]

, 2016
Peer ...
Corripio, I., Isohanni, M., Jaaskelainen, E., Koponen, Hannu, M-RESIST Grp, Miettunen, J., Moilanen, J., Molins, C., Roldan, A., Seppala, A., Seppala, J.   +10 more
core   +2 more sources

Identifying High‐Risk Medications for Drug‐Induced Dystonia: A 20‐Year Retrospective Real‐World Pharmacovigilance Study Based on FAERS

Health Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims Drug‐induced dystonia is a serious, potentially disabling adverse event (AE) associated with certain medications. Despite its clinical relevance, the existing literature is largely limited to case reports or analyses of individual drugs, and a systematic evaluation of medications implicated in dystonia remains lacking. This
Chunhua Chen, Xiaobin Lin, Yi Yang, Jiajia Yan, Jingxiu Chen, Yifan Zheng, Jia Li   +6 more
wiley   +1 more source

Altered Brain Tissue Volumes With Valproate Treatment for Schizophrenia

Journal of the Royal Society of New Zealand, Volume 56, Issue 2, April 2026.
Schizophrenia is a debilitating psychiatric condition that affects ≈0.5% of the global population. Some people with schizophrenia do not respond to first‐line antipsychotics and are prescribed clozapine; this is termed treatment‐resistant schizophrenia (TRS).
Thomas Cawood, Olivia K. Harrison, Meghan McIlwain, Robert R. Kydd, Bruce R. Russell   +4 more
wiley   +1 more source